Singapore markets close in 2 hours 42 minutes
Straits Times Index
3,307.42 +10.53 (+0.32%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,450.28 +243.15 (+1.34%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,526.71 +1,992.07 (+3.46%) CMC Crypto 200
1,298.34 +21.36 (+1.67%)
Biodexa Pharmaceuticals Plc (BDRX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.46M |
| Enterprise value | -1.42M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.07 |
| Price/book (mrq) | 0.93 |
| Enterprise value/revenue | -3.72 |
| Enterprise value/EBITDA | 0.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.57 |
| 52-week change 3 | -92.33% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 20.8000 |
| 52-week low 3 | 0.6700 |
| 50-day moving average 3 | 1.1423 |
| 200-day moving average 3 | 3.1616 |
Share statistics
| Avg vol (3-month) 3 | 3.41M |
| Avg vol (10-day) 3 | 7.71M |
| Shares outstanding 5 | 4.38M |
| Implied shares outstanding 6 | 4.25M |
| Float 8 | 1.19B |
| % held by insiders 1 | 9.94% |
| % held by institutions 1 | 18.94% |
| Shares short (15 Apr 2024) 4 | 189.61k |
| Short ratio (15 Apr 2024) 4 | 0.04 |
| Short % of float (15 Apr 2024) 4 | 4.32% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.32% |
| Shares short (prior month 15 Mar 2024) 4 | 102.63k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 03 Mar 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:80 |
| Last split date 3 | 05 Jul 2023 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,843.37% |
Management effectiveness
| Return on assets (ttm) | -51.38% |
| Return on equity (ttm) | -180.59% |
Income statement
| Revenue (ttm) | 381k |
| Revenue per share (ttm) | 0.48 |
| Quarterly revenue growth (yoy) | -64.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -6.46M |
| Net income avi to common (ttm) | -7.08M |
| Diluted EPS (ttm) | -9.9900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.97M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 464k |
| Total debt/equity (mrq) | 9.92% |
| Current ratio (mrq) | 1.26 |
| Book value per share (mrq) | 1.57 |
Cash flow statement
| Operating cash flow (ttm) | -6.83M |
| Levered free cash flow (ttm) | 348.88k |
© 2024 Yahoo. All rights reserved.